Literature DB >> 18450589

Autoimmune optic neuritis in the common marmoset monkey: comparison of visual evoked potentials with MRI and histopathology.

Ricarda Diem1, Iris Demmer, Susann Boretius, Doron Merkler, Barthel Schmelting, Sarah K Williams, Muriel B Sättler, Mathias Bähr, Thomas Michaelis, Jens Frahm, Wolfgang Brück, Eberhard Fuchs.   

Abstract

PURPOSE: To assess the use of visual evoked potentials (VEPs) for the in vivo detection of impaired visual function in a marmoset model of multiple sclerosis. The sensitivity of the VEP recordings was determined by comparison with magnetic resonance imaging (MRI) and histopathology.
METHODS: Baseline VEPs were recorded in six healthy marmoset monkeys in response to light-flash stimulation. Experimental autoimmune encephalomyelitis (EAE) was induced in four of the six monkeys. Clinical scores were assessed daily, and VEPs were recorded every second week. In vivo MRI and subsequent histopathology of the brains and optic nerves were performed at the end of the study.
RESULTS: After induction of EAE, all four marmosets exhibited clinical signs between day 26 and 38 after immunization. VEPs were normal during the induction phase of the disease, but deteriorated in amplitude with the occurrence of clinical symptoms in all animals. MRI revealed bilateral optic neuritis and signal alterations in the optic tracts and occipital subcortical white matter in two of the animals. In the remaining two animals, MRI detected signal alterations in the occipital subcortical white matter. Histopathologic results were concordant with the MRI findings.
CONCLUSIONS: VEPs are an easily accessible noninvasive tool for measuring visual function and diagnosing impairment of the visual pathway in a marmoset EAE model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450589     DOI: 10.1167/iovs.08-1896

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Neuroprotective effects of gypenosides in experimental autoimmune optic neuritis.

Authors:  Hong-Kan Zhang; Yuan Ye; Zhen-Ni Zhao; Kai-Jun Li; Yi Du; Qiu-Ming Hu; Jian-Feng He
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

2.  Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis.

Authors:  Tsen-Hsuan Lin; William M Spees; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neurobiol Dis       Date:  2014-03-13       Impact factor: 5.996

3.  Evoked potentials as a biomarker of remyelination.

Authors:  Moones Heidari; Abigail B Radcliff; Gillian J McLellan; James N Ver Hoeve; Kore Chan; Julie A Kiland; Nicholas S Keuler; Benjamin K August; Dylan Sebo; Aaron S Field; Ian D Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

4.  Axonal transport rate decreased at the onset of optic neuritis in EAE mice.

Authors:  Tsen-Hsuan Lin; Joong Hee Kim; Carlos Perez-Torres; Chia-Wen Chiang; Kathryn Trinkaus; Anne H Cross; Sheng-Kwei Song
Journal:  Neuroimage       Date:  2014-06-14       Impact factor: 6.556

Review 5.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

Review 6.  Re-evaluating the treatment of acute optic neuritis.

Authors:  Jeffrey L Bennett; Molly Nickerson; Fiona Costello; Robert C Sergott; Jonathan C Calkwood; Steven L Galetta; Laura J Balcer; Clyde E Markowitz; Timothy Vartanian; Mark Morrow; Mark L Moster; Andrew W Taylor; Thaddeus W W Pace; Teresa Frohman; Elliot M Frohman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-29       Impact factor: 10.154

7.  Diffusion MRI quantifies early axonal loss in the presence of nerve swelling.

Authors:  Tsen-Hsuan Lin; Chia-Wen Chiang; Carlos J Perez-Torres; Peng Sun; Michael Wallendorf; Robert E Schmidt; Anne H Cross; Sheng-Kwei Song
Journal:  J Neuroinflammation       Date:  2017-04-07       Impact factor: 8.322

Review 8.  Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.

Authors:  Marcos L Aranda; María Florencia González Fleitas; Hernán Dieguez; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

9.  Overview of the marmoset as a model in nonclinical development of pharmaceutical products.

Authors:  Antonia Orsi; Daryl Rees; Isabella Andreini; Silvana Venturella; Serena Cinelli; Germano Oberto
Journal:  Regul Toxicol Pharmacol       Date:  2010-12-13       Impact factor: 3.271

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.